Navigation Links
Helix BioPharma to Present L-DOS47 Analytical Method Development Findings at 2009 AAPS National Biotechnology Conference
Date:6/19/2009

or additional information on the 2009 AAPS National Biotechnology Conference, please visit http://www.aapspharmaceutica.com/meetings/biotec/bt09/index.asp.

About L-DOS47

L-DOS47 combines Helix's proprietary DOS47 new drug candidate with a highly specific single domain antibody, to form a potential new targeted drug product for the treatment of adenocarcinoma of the lung, the most common form of lung cancer in the world today. L-DOS47 is thought to function by leveraging a natural process in the body called the urea cycle, to produce an anti-cancer effect. It is based upon a naturally occurring enzyme called urease that essentially reverses the urea cycle by breaking down urea into metabolites that include ammonia and hydroxyl ions. By doing so at the site of cancerous tissues in the body, L-DOS47 is believed to modify the microenvironmental conditions of lung cancer cells in a manner that leads to their death. Among these theorized effects, L-DOS47 is believed to stimulate an increase in the pH of the microenvironment surrounding the cancerous cells, effectively reversing the acidic extra-cellular conditions that are known to be necessary for cancer cell survival. As well, the local production of ammonia at the site of cancerous tissues is thought to readily diffuse into the cancer cells to exert a potent cytotoxic effect by interfering with their critical metabolic functions.

About Helix BioPharma Corp.

Helix BioPharma Corp. is a biopharmaceutical company specializing in the field of cancer therapy. The Company is actively developing innovative products for the prevention and treatment of cancer based on its proprietary technologies. Helix's product development initiatives include its Topical In
'/>"/>

SOURCE Helix BioPharma Corp.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Helix BioPharma Announces Q3 2009 Financial Results and Provides Product Development Update
2. Helix BioPharma to Present at the BioFinance 2009 Conference
3. Double Helix Appoints Ann Stuchiner Vice President of US Consulting Division
4. Helix BioPharma Announces Q2 2009 Financial Results
5. Helix BioPharma Receives Approval to Initiate Phase II Pharmacokinetic Clinical Study of Topical Interferon Alpha-2b in Patients with Low-Grade Cervical Lesions
6. Helix BioPharma Form 20-F Registration Statement Declared Effective by SEC
7. London-Based Double Helix Consulting Launches US Division for Strategic Pricing, Reimbursement and Market Access Solutions
8. Helix BioPharma Announces Q1 2009 Financial Results
9. Helix BioPharma Files Form 20-F Registration Statement With the U.S. Securities and Exchange Commission
10. Helix BioPharma Corp. Announces Fiscal 2008 Results
11. Helix Biopharma Closes $11.4 Million Private Placement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Filtration and Separations Society will hold its 23rd Annual Technical Conference ... in San Antonio, Texas. To further impact the separation society and ... proud to announce that the 2010 AFS Annual Technical Conference will ... , ... Minneapolis, MN (PRWEB) December 16, 2009 -- The ...
(Date:12/15/2009)... -- Repligen Corporation (Nasdaq: RGEN ) today ... research funding to support the ongoing development of ... Dystrophy Association (MDA). This grant will support ... GMP manufacture of a drug candidate for human ... only provides important funding for Repligen,s research but ...
(Date:12/15/2009)... Medical, Inc. (OTC Bulletin Board : AEMD) announced ... Comper have joined the Science Advisory ... Schorey and Dr. Comper are leading researchers in ... of Aethlon Medical, was recently formed to leverage ... being advanced as an adjunct therapy for Hepatitis-C ...
(Date:12/15/2009)... (NYSE: MOS ) plans to issue its ... tables on Tuesday, January 5, 2010, after the close ... Results will be available on Mosaic,s website at mosaicco.com/investors. ... call with presentation slides on Wednesday, January 6, 2010, ... at 11:00 a.m. Eastern Standard Time (10:00 a.m. Central ...
Breaking Biology Technology:American Filtration and Separations Society to Hold 23nd Annual Technical Conference 2American Filtration and Separations Society to Hold 23nd Annual Technical Conference 3American Filtration and Separations Society to Hold 23nd Annual Technical Conference 4Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 2Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 3Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 2Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 3Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 4Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 5Mosaic Announces Second Quarter Fiscal Year 2010 Earnings Release and Conference Call 2
... A. How is fold amplification , ... using the Van Gelder and Eberwine technique (Van Gelder 1990) ... the T7 RNA polymerase , promoter ... at the end of mRNA sequences serves as the substrate for the , ...
... More thermostable than AMV RT and M-MLV RT , ... , Highly sensitive enzyme for ... for reverse transcribing transcripts with high , ... reverse transcriptase (RT) and , AMV RT, Ambion's HIV ...
... , , ... , Optimized for highest yield of capped RNA , ... RNase inhibitor, , DNase I, and positive control , ... or in vivo translation , ...
Other Biology Technology:RNA Amplification for Array Analysis 2RNA Amplification for Array Analysis 3RNA Amplification for Array Analysis 4Recombinant HIV Reverse Transcriptase 2Rapidly Synthesize Large Amounts of Capped RNA 2Rapidly Synthesize Large Amounts of Capped RNA 3Rapidly Synthesize Large Amounts of Capped RNA 4
(Date:12/16/2009)... psyched up for contests, but when these rituals involve ... before and during events, they could be causing more ... the symptoms of an injury, not the injury itself," ... on musculoskeletal health and sports medicine. "They may allow ... level, but pain occurs for a reason. It is ...
(Date:12/16/2009)... 2009 Signal Hill, CA Tom Bowman, an ... president of Bowman Global Change, has developed a series ... Intergovernmental Panel on Climate Change (IPCC) report for public ... authentic scientific information they need to make informed decisions ... the new format as a means to clearly and ...
(Date:12/16/2009)... SUNNYVALE, Calif., Dec. 1 GestureTek ... CUBE, Release 3.0 - a turnkey, portable, ... for advertising, exhibits, entertainment and touring promotions. ... dozens of patents in camera-enabled gesture recognition ... systems. ,, Guaranteed for quality, the CUBE ...
Breaking Biology News(10 mins):NSAIDs: Take 'em early and often when competing? Think again 2Bowman creates graphic translation of climate change data 2GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 2GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 3Detroit Clinic Manager Pleads Guilty in Medicare Fraud Scheme 56084 1Detroit Clinic Manager Pleads Guilty in Medicare Fraud Scheme 56084 2Detroit Clinic Manager Pleads Guilty in Medicare Fraud Scheme 56084 3Chindex International Announces September Investor Conferences Participation 56083 1Chindex International Announces September Investor Conferences Participation 56083 2IPC The Hospitalist Company Completes New Jersey Acquisition 56081 1IPC The Hospitalist Company Completes New Jersey Acquisition 56081 2
... they are defined in textbooks, are essential for ... of energy as they use oxygen. However, some ... Entamoeba histolytica, the causal agent of amoebic dysentery--live ... support this process. Nevertheless, Entamoeba still contains a ...
... identifies 34 regions worldwide where 75 percent of the ... habitat covering just 2.3 percent of the Earth's surface ... largest U.S. states). This habitat originally covered 15.7 percent ... to Russia and Australia combined. The new analysis shows ...
... evidence that a single protein is critical in the ... hemochromatosis, researchers report in the March issue of Cell ... 300 people in Western populations --causes tissues of the ... hereditary disease can lead to organ failure. , The ...
Other Biology News:Biodiversity hotspots identify conservation priorities 2Biodiversity hotspots identify conservation priorities 3Biodiversity hotspots identify conservation priorities 4Biodiversity hotspots identify conservation priorities 5Iron exporter revealed that may explain common human disorder 2Iron exporter revealed that may explain common human disorder 3
... The Fujifilm Life Science LAS-3000 ... technology with a simplified user interface, ... a wide range of modularities. The ... applications, and the perfect standard system ...
... Life Science LAS-3000mini is a compact ... chemiluminescence applications, and the perfect standard ... 's LAS-3000 provides significantly improved system ... Glowell calibration standards validate that Fujis ...
... assays. The TUNEL-based assay kit provides complete ... for convenient detection of DNA fragmentation in ... offers an one-step labeling of apoptotic cells. ... hallmark of apoptosis in mammalian cells. MBLs ...
SDS-OutT Precipitation Reagent...
Biology Products: